Empower Advisory Group
AZN icon

Empower Advisory Group’s AstraZeneca AZN Stock Holding History

Empower Advisory Group’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.15M Buy
5,928
+3,707
+167% +$715K ﹤0.01% 236
2025
Q4 		$408K Sell
2,221
-541
-20% -$94.9K ﹤0.01% 364
2025
Q3 		$424K Buy
2,762
+258
+10% +$39K ﹤0.01% 362
2025
Q2 		$350K Sell
2,504
-113
-4% -$15.8K ﹤0.01% 376
2025
Q1 		$385K Buy
2,617
+94
+4% +$13.6K ﹤0.01% 355
2024
Q4 		$331K Buy
2,523
+691
+38% +$96.7K ﹤0.01% 387
2024
Q3 		$285K Sell
1,832
-2,130
-54% -$344K ﹤0.01% 412
2024
Q2 		$618K Sell
3,962
-1,394
-26% -$210K ﹤0.01% 279
2024
Q1 		$726K Sell
5,356
-236
-4% -$31.3K ﹤0.01% 256
2023
Q4 		$753K Buy
5,592
+374
+7% +$48.6K ﹤0.01% 251
2023
Q3 		$707K Buy
5,218
+47
+0.9% +$6.42K ﹤0.01% 254
2023
Q2 		$740K Buy
5,171
+199
+4% +$29.3K ﹤0.01% 256
2023
Q1 		$695K Buy
+4,972
New +$669K ﹤0.01% 270

Other funds holding AZN

IA
Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
VAM
Vanguard Asset Management London, Ec4n 8af $117B AUM

Empower Advisory Group's AZN Position: Q1 2026 in Review

Empower Advisory Group increased its AstraZeneca (AZN) stake by 167% in Q1 2026, buying an estimated $715K and bringing the position to 5,928 shares worth $1.15M. The position accounts for ﹤0.01% of the portfolio, ranked #236.

Empower Advisory Group first reported a position in AZN in Q1 2023 and has held it in 13 quarters since. 1,377 funds tracked by Wall St. Rank hold AZN as of Q1 2026.

  • Empower Advisory Group held 5,928 shares of AstraZeneca worth $1.15M as of Q1 2026.
  • Empower Advisory Group bought 3,707 AstraZeneca shares in Q1 2026, an estimated $715K.
  • AstraZeneca made up ﹤0.01% of Empower Advisory Group's portfolio in Q1 2026, its #236 holding.
  • Empower Advisory Group first reported a position in AstraZeneca in Q1 2023 and has held it in 13 quarters since.
  • 1,377 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.

Based on Empower Advisory Group's 13F filing for Q1 2026, filed 14 May 2026.